Showing results (221-230 of 250) with videos related to
Sort By:
Pageof 25
JAMA|July 10, 2014
Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trialJean Marc Regimbeau, David Fuks, Karine Pautrat, et al.Frontiers in Oncology|June 1, 2022
Selected Patients With Peritoneal Metastases From Breast Cancer May Benefit From Cytoreductive Surgery: The Results of a Multicenter SurveyMaurizio Cardi, Marc Pocard, Rea Lo Dico, et al.International Journal of Cancer|November 13, 2020
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohortThomas Aparicio, Magali Svrcek, Julie Henriques, et al.Lancet (London, England)|June 12, 2017
Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trialEric Rullier, Philippe Rouanet, Jean-Jacques Tuech, et al.International Journal of Cancer|January 9, 2020
Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patientsThomas Aparicio, Julie Henriques, Sylvain Manfredi, et al.The Lancet. Gastroenterology & Hepatology|February 12, 2020
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trialEric Rullier, Véronique Vendrely, Julien Asselineau, et al.The Lancet. Oncology|July 5, 2005
Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trialBernard Nordlinger, Philippe Rougier, Jean-Pierre Arnaud, et al.Annals of Surgical Oncology|February 28, 2018
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional ExperienceYang Liu, Yutaka Yonemura, Edward A Levine, et al.Surgical Oncology|April 30, 2026
Colorectal peritoneal metastases treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Should we consider the primary tumour site?Fatah Tidadini, Olivier Glehen, Isabelle Sourrouille, et al.Journal of Neuropathology and Experimental Neurology|January 7, 2016
Prognostic and Therapeutic Markers in Chordomas: A Study of 287 TumorsArnault Tauziéde-Espariat, Damien Bresson, Marc Polivka, et al.Pageof 25